Attached files

file filename
10-K/A - FORM 10-K/A - MEDISAFE 1 TECHNOLOGIES CORPv227517_10ka.htm
EX-23 - CONSENT OF INDEPENDENT AUDITORS - MEDISAFE 1 TECHNOLOGIES CORPv227517_ex23.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO EXCHANGE ACT RULE 13A - MEDISAFE 1 TECHNOLOGIES CORPv227517_ex31-2.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(A) OF THE - MEDISAFE 1 TECHNOLOGIES CORPv227517_ex32-2.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A- - MEDISAFE 1 TECHNOLOGIES CORPv227517_ex31-1.htm
 
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Jacob Elhadad   the Chief Executive Officer,  and Director of Medisafe 1 Technologies Corp  , certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K/A #3 of the Registrant for the fiscal year ended December 31, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-K/A #3 fairly presents, in all material respects, the financial condition and  results of operations of the Registrant.

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Date: July 1, 2011
Medisafe 1 Technologies Corp
   
 
By:
/s/ Jacob Elhadad
 
 
Name:  Jacob Elhadad
 
Title:    Chief Executive Officer, and Director
 
A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.